Cost-Effectiveness Analysis Comparing Conventional Versus Stereotactic Body Radiotherapy for Surgically Ineligible Stage I Non–Small-Cell Lung Cancer Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • The authors show that based on a threshold of $50,000 per life-year gained, stereotactic body radiotherapy seems cost effective compared with conventionally fractionated radiotherapy.

authors

  • Mitera, Gunita
  • Swaminath, Anand
  • Rudoler, David
  • Seereeram, Colleen
  • Giuliani, Meredith
  • Leighl, Natasha
  • Gutierrez, Eric
  • Dobrow, Mark J
  • Coyte, Peter C
  • Yung, Terence
  • Bezjak, Andrea
  • Hope, Andrew J

publication date

  • May 2014